Biopharma
R&D Workflows.
Revolutionized.
Join leading biopharma in transforming R&D.
Automate and connect scientific data and analysis workflows for all modalities across discovery, development, and manufacturing. Eliminate manual data management and turn complex processes into insight-driven decisions. With Genedata.
Our Customers
All Modalities
Genedata supports all therapeutic modalities in one integrated platform, eliminating siloed point solutions and providing a single source of truth for all data and processes.
- Biotherapeutics and Next-Gen Antibodies
- Antibody-Drug Conjugates
- Cell Therapies
- Gene Therapies
- CRISPR Therapies
- RNA Therapies
- Vaccines
- Small Molecules
- Support for monoclonal antibodies, bispecifics, multispecifics, and other complex biologics throughout discovery and optimization.
- Integrated workflows for library design, screening, hit triage, engineering, and developability assessment.
- Registration, tracking, and analytics for large molecule entities with complete molecular history.
- Dedicated workflows for managing conjugation, payload-linker design, and complex characterization data.
- Integrated chromatography and MS analytics to monitor DAR, stability, and critical quality attributes.
- Purpose-built workflows for designing, engineering, and developing cell therapy products with full traceability across vectors, cells, and processes.
- Integrated analytics to connect NGS, flow cytometry, imaging, and functional assays for in-depth product characterization and performance assessment.
- Dedicated workflows for managing vector design, genome integration strategies, and complex characterization data throughout gene therapy development.
- Seamless integration with NGS and other analytical technologies for assessing integration sites, off-target effects, and long-term product quality.
- Specialized workflows to orchestrate CRISPR target design, editing strategies, and verification within a single, controlled environment.
- Automated analytics that combine NGS, functional readouts, and QC data for robust evaluation of on-target activity and off-target risk.
- Integrated workflows to support RNA design, production, formulation, and analytical characterization for mRNA and other RNA modalities.
- Consolidated assay and process data to optimize RNA quality, stability, and performance across discovery, development, and CMC.
- Digitalized workflows for nucleic acid, viral vector, and protein-based vaccine programs from early discovery through development.
- Unified analytical data streams to monitor immunogenicity, safety, and critical quality attributes for diverse vaccine candidates.
- High-throughput screening and profiling workflows for small molecules, integrated with biophysical and functional assays.
- Standardized analytics that enable the rapid progression of high-value candidates and portfolio-level insights.
Empowering Scientists, Data Experts, IT, and Quality
The Genedata Biopharma Platform enables scientists, data experts, IT, and quality teams to collaborate in one shared system with role-specific tools on a governed data backbone.
Experimental Scientists
Computational Scientists
IT & Software Engineers
Driving Operational Excellence in Biopharma
By connecting workflows, data, and teams, Genedata enables true operational excellence across the biopharma value chain. Organizations can scale complex pipelines, reduce cycle times, and systematically capture process knowledge from discovery through clinical development and manufacturing. Operational impact:
- Reduction of manual data processing and reporting efforts through automation and standardization.
- Improved collaboration across internal groups and external partners based on a single, trusted data backbone.
- Better portfolio and program decisions fueled by harmonized, analytics-ready data and cross-workflow insights.